Literature DB >> 24813818

Risk factors associated with rectal neuroendocrine tumors: a cross-sectional study.

Yoon Suk Jung1, Kyung Eun Yun2, Yoosoo Chang3, Seungho Ryu3, Jung Ho Park1, Hong Joo Kim1, Yong Kyun Cho1, Chong Il Sohn1, Woo Kyu Jeon1, Byung Ik Kim1, Dong Il Park4.   

Abstract

BACKGROUND: The incidence of rectal neuroendocrine tumors (NET) has been increasing since the implementation of the screening colonoscopy. However, very little is known about risk factors associated with rectal NETs. We examined the prevalence of and the risk factors for rectal NETs in a Korean population.
METHODS: A cross-sectional study was performed on 62,171 Koreans who underwent screening colonoscopy. The clinical characteristics and serum biochemical parameters of subjects with rectal NET were compared with those of subjects without rectal NET using multivariate logistic regression.
RESULTS: Of a total of 57,819 participants, 101 [OR, 0.17%; 95% confidence interval (CI), 0.14-0.20] had a rectal NET. Young age (<50 years; OR, 2.09; 95% CI, 1.06-4.15), male gender (OR, 1.92; 95% CI, 1.15-3.20), alcohol drinking [adjusted OR (AOR), 1.56; 95% CI, 1.01-2.42], and a low high-density lipoprotein-cholesterol (HDL-C) level (AOR, 1.85; 95% CI, 1.10-3.11) were independent risk factors for rectal NETs. Cigarette smoking, fatty liver, metabolic syndrome, higher triglyceride level (≥150 mg/dL), and higher homeostasis model assessment of insulin resistance (≥2.5) were not independently associated with rectal NETs, although these factors were more common in individuals with rectal NETs in the univariate analysis.
CONCLUSIONS: Young age (<50 years), male gender, alcohol drinking, and a low HDL-C level were risk factors for rectal NETs. Our results suggest that gender, behavioral factors, and dyslipidemia may affect the risk for developing rectal NETs. IMPACT: The findings of this study contribute to a better understanding of the influence of gender, behavioral factors, and dyslipidemia in developing rectal NETs. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24813818     DOI: 10.1158/1055-9965.EPI-14-0132

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  14 in total

1.  Clinical characteristics, risk factors and outcomes of asymptomatic rectal neuroendocrine tumors.

Authors:  Sun-Hye Ko; Myong Ki Baeg; Seung Yeon Ko; Hee Sun Jung
Journal:  Surg Endosc       Date:  2017-01-11       Impact factor: 4.584

2.  Comparison of characteristics between true rectal neuroendocrine tumors and rectal hyperplastic polyps among patients with endoscope-diagnosed rectal neuroendocrine tumors.

Authors:  Yan Weng; Jingxue Ran; Yongmei Peng; Yining Xiang; Liangbi Xu
Journal:  J Gastrointest Oncol       Date:  2022-06

3.  Epidemiological, clinical and endoscopic characteristics of colorectal neuroendocrine neoplasms: a population-based study in the Netherlands.

Authors:  Ankie Reumkens; Prapto Sastrowijoto; Heike I Grabsch; Danny Goudkade; Chantal le Clercq; Minke Bakker; Eric Keulen; Rogier de Ridder; Wouter W de Herder; Bjorn Winkens; Silvia Sanduleanu; Judith de Vos-Geelen; Ad Masclee
Journal:  Endosc Int Open       Date:  2022-07-15

4.  Evaluation of the risk factors associated with rectal neuroendocrine tumors: a big data analytic study from a health screening center.

Authors:  Jeung Hui Pyo; Sung Noh Hong; Byung-Hoon Min; Jun Haeng Lee; Dong Kyung Chang; Poong-Lyul Rhee; Jae Jun Kim; Sun Kyu Choi; Sin-Ho Jung; Hee Jung Son; Young-Ho Kim
Journal:  J Gastroenterol       Date:  2016-03-30       Impact factor: 7.527

5.  Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study.

Authors:  Qiwen Ben; Jie Zhong; Jian Fei; Haitao Chen; Lifen Yv; Jihong Tan; Yaozong Yuan
Journal:  Sci Rep       Date:  2016-10-26       Impact factor: 4.379

6.  Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Ana P Santos; Ana C Santos; Clara Castro; Luís Raposo; Sofia S Pereira; Isabel Torres; Rui Henrique; Helena Cardoso; Mariana P Monteiro
Journal:  Cancers (Basel)       Date:  2018-08-27       Impact factor: 6.639

7.  Disseminated Well-Differentiated Gastro-Entero-Pancreatic Tumors Are Associated with Metabolic Syndrome.

Authors:  Ana P Santos; Clara Castro; Luís Antunes; Rui Henrique; M Helena Cardoso; Mariana P Monteiro
Journal:  J Clin Med       Date:  2019-09-17       Impact factor: 4.241

8.  Efficacy and safety of hybrid endoscopic submucosal dissection compared with endoscopic submucosal dissection for rectal neuroendocrine tumors and risk factors associated with incomplete endoscopic resection.

Authors:  Xiang-Yao Wang; Ning-Li Chai; En-Qiang Linghu; Hui-Kai Li; Ya-Qi Zhai; Xiu-Xue Feng; Wen-Gang Zhang; Jia-Le Zou; Long-Song Li; Jing-Yuan Xiang
Journal:  Ann Transl Med       Date:  2020-03

9.  A small, well-differentiated rectal neuroendocrine tumor with multiple lymph node metastases: A case report.

Authors:  Seung-Joo Nam; Gi Bong Chae; Seungkoo Lee; Sung Chul Park; Chang Don Kang; Sung Joon Lee
Journal:  Oncol Lett       Date:  2018-03-14       Impact factor: 2.967

10.  Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade.

Authors:  Arthur I Kooyker; Wieke Hm Verbeek; José G van den Berg; Margot Et Tesselaar; Monique E van Leerdam
Journal:  United European Gastroenterol J       Date:  2019-07-15       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.